A new company with a broader mission and product set, the name Pharmaspectra better communicates our goal of solving problems across the biopharma spectrum, from drug discovery through post-marketing.
If the drug gains full FDA approval in January 2018, it will be the first ever gene cell therapy approved for an inherited disease.
KOL as a term isn’t going anywhere anytime soon. That was the takeaway from a recent Medical Science Liaison Society and the term is taking on other meanings as well
Put simply, newer generations of physicians seek sources of information beyond traditional Pharma reps and inputs from other credible sources, with the goal of making the most informed decision possible.
Biases can skew the clinical data that Pharma relies upon to make sound research and development decisions. Here are ways to minimize this problem.